20247 ⎘
Medicinal preparations containing organic active ingredients; Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids; Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
Neurodegenerative disorders and muscle diseases implicating PUFAs
#1802Medical food for cognitive decline
#1803Sn-2-monoacylglycerols and lipid malabsorption
#1804Stable Compositions of HMG-COA Reductase Inhibitors and Omega-3 Oils
#1805Compositions containing enriched natural crocin and/or crocetin, and their therapeutic or nutraceutical uses
#1806SOFT CAPSULE PREPARATION, COMPOSITION FOR SOFT CAPSULE PREPARATION, AND METHOD OF PRODUCING SOFT CAPSULE PREPARATION
#1807COMPOSITIONS CONTAINING NITRO FATTY ACIDS
#1808Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA
#1809Method for alleviating fear memory
#1810Composition for accelerating change in muscle type
#1811Alcoholic injury mitigating agent
#1812Drug combinations and methods for reducing or maintaining cholesterol or HDL/LDL levels
#1813Strain of microalga that produces squalene
#1814Lipid-lowering antidiabetic agent
#1815OMEGA-3 PENTAENOIC ACID COMPOSITIONS AND METHODS OF USE
#1816OMEGA-3 PENTAENOIC ACID COMPOSITIONS AND METHODS OF USE
#1817OMEGA-3 PENTAENOIC ACID COMPOSITIONS AND METHODS OF USE
#1818OMEGA-3 PENTAENOIC ACID COMPOSITIONS AND METHODS OF USE
#1819OMEGA-3 PENTAENOIC ACID COMPOSITIONS AND METHODS OF USE
#1820New Method For Making Krill Meal
#1821OSTEOARTHRITIS DIET FORMULATIONS
#1822Prepared foods having high efficacy omega-6/omega-3 balanced polyunsaturated fatty acids
#1823Oil composition, formulations comprising the oil composition, and the use thereof to reduce accumulation of visceral fat, improve glucose tolerance, and prevent or treat obesity related diseases and disorders
#1824Preventing diseases in infants delivered via caesarean section
#1825OMEGA-3 PENTAENOIC ACID COMPOSITIONS AND METHODS OF USE
#1826METHODS OF ADMINISTERING COMPOSITIONS COMPRISING DOCOSAPENTAENOIC ACID
#1827METHODS OF ADMINISTERING COMPOSITIONS COMPRISING DOCOSAPENTAENOIC ACID
#1828Methods of administering compositions comprising docosapentaenoic acid
#1829METHODS OF ADMINISTERING COMPOSITIONS COMPRISING DOCOSAPENTAENOIC ACID
#1830extract, extraction process and its use as cholesteryl ester transferase protein (CETP) inhibitor
#1831Omega-3 pentaenoic acid compositions and methods of use
#1832NUTRITIONAL COMPOSITIONS WITH LARGE LIPID GLOBULE SIZE
#1833Stable pharmaceutical composition and methods of using same
#1834USE OF LONG CHAIN POLYUNSATURATED FATTY ACID DERIVATIVES TO TREAT SICKLE CELL DISEASE
#1835Composition useful for the treatment of lipid metabolism disorders
#1836Stable pharmaceutical composition and methods of using same
#1837Statin and Omega-3 Fatty Acids for Lipid Therapy
#1838PHARMACEUTICAL COMPOSITION COMPRISING AN OMEGA-3 FATTY ACID AND A HYDROXY-DERIVATIVE OF A STATIN AND METHODS OF USING SAME
#1839Compositions and methods for the treatment of cancer
#1840Anti-inflammatory particles
#1841HIGHLY PURIFIED ETHYL EPA AND OTHER EPA DERIVATIVES
#1842Andrographis Paniculata Compositions and Methods for Treatment of Addictions
#1843Cosmetic compositions comprising EPA and GLA and methods of making and using same
#1844Cosmetic compositions comprising EPA and salicylic acid and methods of making and using same
#1845Method for treating neurotrauma
#1846Self-emulsifying composition of OMEGA3 fatty acid
#1847COMPOSITIONS COMPRISING EXTRACTS OR FRACTIONS DERIVED FROM ANNONA SQUAMOSA FOR THE PREVENTION, TREATMENT OR CONTROL OF INFLAMMATORY AND METABOLIC DISORDERS
#1848NUTRITIONAL COMPOSITIONS HAVING ALPHA-HICA AND EICOSAPENTAENOIC ACID
#1849Method for manufacturing phosphonocrotonic acid derivative
#1850Stabilized formulation comprising omega-3 fatty acids and use of the fatty acids for skin care and/or wound care
#1851Disorders implicating PUFA oxidation
#1852Plant derived seed extract rich in essentially fatty acids derived from L. seed: composition of matter, manufacturing process and use
#1853OIL BODY EXTRACTION AND USES
#1854Oxidative retinal diseases
#1855Impaired energy processing disorders and mitochondrial deficiency
#1856THERAPEUTIC AGENT FOR DIASTOLIC CONGESTIVE HEART FAILURE
#1857FORMULATIONS OF LIPOPHILIC BIOACTIVE MOLECULES
#1858NUTRITIONAL COMPOSITIONS INCLUDING BRANCHED CHAIN FATTY ACIDS FOR IMPROVING GUT BARRIER FUNCTION
#1859NUTRITIONAL COMPOSITIONS INCLUDING BRANCHED CHAIN FATTY ACIDS FOR WOUND HEALING
#1860NUTRITIONAL COMPOSITIONS FOR INCREASING ARGININE LEVELS AND METHODS OF USING SAME
#1861Methods for improving the quality of the meibum composition of meibomian glands
#1862Plant derived seed extract rich in essentially fatty acids derived from L. seed: composition of matter, manufacturing process and use
#1863Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA
#1864THERAPEUTIC METHODS
#1865COMPOSITIONS COMPRISING A FATTY ACID OIL MIXTURE, A FREE FATTY ACID, AND A STATIN
#1866Stable pharmaceutical composition and methods of using same
#1867Compositions and methods for the prevention of cardiovascular disease
#1868Nitro fatty acids—neuroprotection and/or inhibition of cognitive decline
#1869Composition and method for treatment of diabetes
#1870Krill oil and carotenoid composition, associated method and delivery system
#1871Bioeffective krill oil compositions
#1872Krill oil and carotenoid composition, associated method and delivery system
#1873Methods for producing bioeffective krill oil compositions
#1874Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA
#1875TOPICAL FORMULATIONS FOR ADMINISTRATION OF OMEGA-3 FATTY ACIDS
#1876METHODS FOR TREATING HYPERTRIGLYCERIDEMIA
#1877Compositions and methods useful for ameliorating age related maladies
#1878COMPOSITIONS COMPRISING A FATTY ACID OIL MIXTURE COMPRISING EPA AND DHA IN FREE ACID FORM, A SURFACTANT, AND A STATIN
#1879POWDER EMULSIFIER
#1880Supplement composition and method of use
#1881WEIGHT LOSS AND SATIATION COMPOSITION
#1882Supplement composition and method of use to treat anhidrosis
#1883Compositions and methods for treating depression
#1884Non-medical increase or maintenance of body weight of a mammal
#1885Plant derived seed extract rich in essential fatty acids derived from perilla seed: composition of matter, manufacturing process and use
#1886METHODS AND COMPOSITIONS FOR TREATING, REDUCING OR PREVENTING DAMAGE TO THE NERVOUS SYSTEM OF ANIMALS
#1887METHODS OF TREATING HYPERCHOLESTEROLEMIA
#1888Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA
#1889Plant derived seed extract rich in essential fatty acids derived from seed: composition of matter, manufacturing process and use
#1890Compositions containing as the active ingredient components from seed
#1891COMPOSITIONS CONTAINING HIGH OMEGA-3 AND LOW SATURATED FATTY ACID LEVELS
#1892Reduction of risk of obesity
#1893Composition Comprising OPC and Omega-3 for Preventing and/or Inhibiting the Development of Diabetic Retinopathy
#1894NOVEL OMEGA-3 AND OMEGA-6 FATTY ACID COMPOSITIONS AND USES THEREOF
#1895COMPOSITIONS OF STATINS AND OMEGA-3 FATTY ACIDS
#1896Composition for improving membrane composition and functioning of cells
#1897Composition and method to improve blood lipid profiles and optionally reduce low density lipoprotein (LDL) per-oxidation in humans
#1898Composition and method to alleviate joint pain
#1899Lipid-lowering antidiabetic agent
#1900Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
#1901Composition and method to alleviate joint pain
#1902Soft Elastic Capsules Containing Tablets and Liquid or Semisolid Fills and Methods for Their Manufacture
#1903PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA, 15-OHEPA, AND/OR 15-HETRE AND METHODS OF REDUCING SEBUM PRODUCTION USING SAME
#1904Use of DHA, EPA or DHA-derived EPA for treating a pathology associated with cellular oxidative damage
#1905Compositions and methods for the prevention and treatment of diseases or conditions associated with oxidative stress, inflammation, and metabolic dysregulation
#1906PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA, 15-OHEPA, AND/OR 15-HETRE AND METHODS OF REDUCING SEBUM PRODUCTION USING SAME
#1907OPTIMIZED NUTRITIONAL FORMULATIONS, METHODS FOR SELECTION OF TAILORED DIETS THEREFROM, AND METHODS OF USE THEREOF
#1908CLINICAL BENEFITS OF EICOSAPENTAENOIC ACID IN HUMANS
#1909Anti-leishmanial compound and anti-leishmanial drug
#1910THERAPEUTIC OR PROPHYLACTIC AGENT FOR CORNEAL EPITHELIUM DISORDERS AND/OR CONJUNCTIVAL EPITHELIUM DISORDERS
#1911Purified crocetin compound and method for treating, inhibiting, and/or prophylaxis of cancer, such as pancreatic cancer
#1912NOVEL OMEGA-3 AND OMEGA-6 FATTY ACID COMPOSITIONS AND USES THEREOF
#1913METHOD AND PREPARATION FOR THE TREATMENT OR PREVENTION OF ANXIETY OR NEUROGENESIS
#1914Composition and method for recovery from mild traumatic brain injury
#1915RESOLVINS: BIOEMPLATES FOR NOVEL THERAPEUTIC INTERVENTIONS
#1916Pharmaceutical semi-solid composition of isotretinoin
#1917DIETARY SUPPLEMENT FOR ENHANCING ANIMAL HEALTH
#1918OMEGA 3 FATTY ACID FORMULATIONS
#1919HYALURONIC ACID CONTAINING PHARMACEUTICAL OR VETERINARY COMPOSITIONS
#1920DPA-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form
#1921Tube feed packages and methods for using same
#1922COMPOSITIONS CONTAINING OMEGA-3 OIL AND USES THEREOF
#1923Supporting activities of daily living
#1924COMPOSITION COMPRISING A COMBINATION OF DHA AND EPA FOR ADMINISTRATION PRIOR TO COMMENCEMENT OF CHEMOTHERAPY
#1925Procedure for the obtainment of fatty acids of pharmacological and nutritional interest
#1926Methods and formulations for administration of resolvin anti-inflammatory compounds
#1927Methods and compositions for oral administration of exenatide
#1928Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof
#1929Synthesis and use of omega-3 and omega 6 very long chain polyunsaturated fatty acids (VLC-PUFA)
#1930Compositions and methods for lowering levels of high-sensitivity C-reactive protein (HS-CRP) in a subject
#1931Method for increasing performance of offspring
#1932Nutritional Compensation For Western-Type Diet
#1933DPA-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form
#1934Methods for Improving Cognitive Function and Decreasing Heart Rate
#1935Inhibition of Cancer Cell Proliferation Using Oleoylethanolamide
#1936Functional Food Supplement Intended, In Particular, For Nutrition And For Prevention And Improvement of Neurological Alterations, Neurodegenerative Alterations Or Cognitive Disorders
#1937ALPHA-GLUCOSIDASE INHIBITOR
#1938Pharmaceutical semi-solid composition of isotretinoin
#1939Preparation for the prevention and/or treatment of vascular disorders
#1940Composition and method of manufacture
#1941Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers
#1942Diene compounds for use in human epidermal cell repair, and pharmaceutical and cosmetic compositions containing them
#1943Fatty acids for use as a medicament
#1944Intravenous omega-3 fatty acid compositions and method of use
#1945Methods and Compositions for Treating Arthritis with Docosahexaenoic Acid
#1946COMBINATIONS OF NIACIN COMPOUNDS, OMEGA-3 FATTY ACID COMPOUNDS, AND PHYTOSTEROL COMPOUNDS FOR PREVENTION AND/OR MITIGATION OF ERECTILE DYSFUNCTION
#1947Medicinal agent for prevention and/or treatment of hepatocellular carcinoma
#1948Type A gelatin capsule containing PUFA in free acid form
#1949Fatty acids and metal ions compositions and uses thereof
#1950Fluid Supplement with Prenatal Vitamins
#1951SN-2-MONOACYLGLYCEROLS AND LIPID MALABSORPTION
#1952Coated capsules and tablets of a fatty acid oil mixture
#1953Compounds with a skin pigmenting activity and pharmaceutical or cosmetic compositions containing them
#1954Methods of treating hypertriglyceridemia
#1955Pharmaceutical compositions comprising DGLA, 15-HEPE, and/or 15-HETrE and methods of use thereof
#1956NUTRITIONAL COMPOSITION COMPRISING IMMUNOGLOBULINS AND OLIGOSACCHARIDES
#1957HAIR GROWTH STIMULANT
#1958Pharmaceutical compositions comprising DGLA and/or 15-HETrE and methods of use thereof
#1959Compositions and methods for treating nephropathy
#1960Methods of treating hypertriglyceridemia
#1961INFANT NUTRITION FOR IMPROVING FATTY ACID COMPOSITION OF BRAIN MEMBRANES
#1962METHODS AND COMPOSITIONS FOR TREATING, REVERSING, INHIBITING OR PREVENTING RESISTANCE TO ANTIPLATELET THERAPY
#1963Pharmaceutical composition comprising eicosapentaenoic acid and nicotinic acid and methods of using same
#1964Stable pharmaceutical composition and methods of using same
#1965Pharmaceutical methods and topical compositions containing acitretin
#1966Compositions, kits and methods for nutrition supplementation
#1967Stable pharmaceutical composition and methods of using same
#1968Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels
#1969Infant nutrition for improving fatty acid composition of brain membranes
#1970Composition and/or method for preventing onset and/or recurrence of cardiovascular events
#1971Compositions for improving the quality of the meibum composition of inflamed or dysfunctional meibomian glands
#1972DENTINAL DRUG DELIVERY COMPOSITION AND SCREENING METHOD
#1973Lipid compositions with high DHA content
#1974Intestinal barrier integrity
#1975Compositions and Methods for Treating Pain
#1976Method for weight loss and ketogenic compositions
#1977Treatment for Concussion using Gallium Compounds
#1978COMPOSITIONS AND METHODS FOR THE PREVENTION OF CARDIOVASCULAR DISEASE
#1979USE OF CIS-EPOXYEICOSATRIENOIC ACIDS AND INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE TO TREAT CONDITIONS MEDIATED BY PBR, CB2, and NK2 RECEPTORS
#1980Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events
#1981Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels
#1982Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (CVD) and diabetics
#1983COMPOSITION AND METHOD FOR TREATING MIGRAINES
#1984TOPICAL TRANSDERMAL METHOD FOR DELIVERING NUTRIENTS THROUGH THE SKIN FOR EXPEDITED WOUND HEALING
#1985Lipid composition for improving brain function
#1986Compositions containing non-polar compounds
#1987Composition for accelerating change in muscle type
#1988Methods of treating hypertriglyceridemia
#1989COMPOSITIONS AND METHODS FOR LOWERING TRIGLYCERIDES WITHOUT RAISING LDL-C LEVELS IN A SUBJECT ON CONCOMITANT STATIN THERAPY
#1990Visual performance and/or macular pigmentation
#1991Stable pharmaceutical composition and methods of using same
#1992Stable pharmaceutical composition and methods of using same
#1993KRILL OIL AND CAROTENOID COMPOSITION, ASSOCIATED METHOD AND DELIVERY SYSTEM
#1994Fatty acid composition for treatment of Alzheimer's disease and cognitive dysfunction
#1995COMPOSITIONS, KITS AND METHODS FOR NUTRITION SUPPLEMENTATION
#1996Composition and method to alleviate joint pain
#1997Glycogen or polysaccharide storage disease treatment method
#1998Methods of treating hypertriglyceridemia
#1999Esters for treatment of ocular inflammatory conditions
#2000Methods of treating mixed dyslipidemia
#2001Compositions, methods and kits for treating leukemia
#2002SYNERGISTIC COMPOSITION AND METHOD OF RETARDING AND AMELIORATING PHOTO INDUCED RETINAL DAMAGE AND CATARACTS WHILE AMELIORATING DRY EYE SYNDROME
#2003Esters for treatment of ocular inflammatory conditions
#2004HYDROXYTYROSOL COMPOSITIONS FOR TREATMENT OF CARTILAGE INJURIES IN JOINTS
#2005Composition and method to alleviate joint pain
#2006Stable pharmaceutical composition and methods of using same
#2007Methods of treating hypertriglyceridemia
#2008Methods of treating hypertriglyceridemia
#2009Methods of treating hypertriglyceridemia
#2010Composition for preventing the occurrence of cardiovascular event in multiple risk patient
#2011Omega-3 fatty acid nutriceutical composition and optimization method
#2012OMEGA 3 FORMULATIONS FOR TREATMENT OF RISK FACTORS FOR CARDIOVASCULAR DISEASE AND PROTECTION AGAINST SUDDEN DEATH
#2013Methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
#2014Methods of treating inflammatory conditions
#2015Dermatological compositions comprising a fat or oil of an essential fatty acid triglyceride for treating of skin, mucosa, hair, nails, or scalp
#2016Methods for measuring enhancement in the quality of life of an animal
#2017Diacylglycerol acyltransferase genes and use thereof
#2018USE OF A FATTY ACID COMPOSITION CONTAINING DHA FOR THE PRODUCTION OF A MEDICAL PRODUCT OR A FOOD STUFF FOR THE TREATMENT OF AMYLOIDOS-RELATED DISEASES
#2019METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING PARENTERAL NUTRITION ASSOCIATED LIVER DISEASE
#2020LIPOXIN COMPOUNDS AND THEIR USE IN TREATING CELL PROLIFERATIVE DISORDERS
#2021COMBINATIONS OF NIACIN, OMEGA-3 AND PLANT STEROLS/STANOLS FOR PREVENTION CHOLESTEROL TREATMENT
#2022Compositions and methods for reducing or preventing obesity
#2023Method of improving animal tissue quality by supplementing the animal diet with oleic acid and selected tocols
#2024Fatty acid niacin conjugates and their uses
#2025Use of docosatrienes, resolvins, and their stable analogs in the treatment of airway diseases and asthma
#2026ANTIMICROBIAL COMPOSITIONS COMPRISING 15-HETRE AND METHODS OF USE THEREOF
#2027METHODS AND COMPOSITIONS TO PROMOTE OCULAR HEALTH
#2028Bioavailability enhancement delivery composition
#2029Compositions and Methods for Treating Neurologic Disorders
#2030Niacin conjugated fatty acid mixtures and their uses
#2031Regulating the Amino Acid Pool Used for the Acute-Phase Protein Synthesis
#2032COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF
#2033Probiotic sports nutrition compositions
#2034METHOD FOR TREATING NEUROPATHIC PAIN
#2035Methods and compositions for promoting the respiratory development of an infant
#2036METHODS OF TREATING HYPERTRIGLYCERIDEMIA
#2037Immune response modifier formulations containing oleic acid and methods
#2038SUPPOSITORY FOR RECTAL, VAGINAL OR URETHRAL ADMINISTRATION CONTAINING A PROBIOTIC, AN ANTIBIOTIC AND AN UNSATURATED NON-ESTERIFIED FATTY ACID
#2039Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
#2040Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy
#2041Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof
#2042Marker associated with non-alcoholic steatohepatitis
#2043Compositions comprising a fatty acid oil mixture and a surfactant, and methods and uses thereof
#2044Stable pharmaceutical composition and methods of using same
#2045Composition with preventive or improvement effect on symptoms or diseases associated with stress-induced behavior disorders
#2046METHODS FOR DIAGNOSIS AND TREATMENT OF CHRONIC FATIGUE SYNDROME
#2047COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES THEREOF AND USES THEREOF
#2048Use of pufas for treating skin inflammation
#2049Method for treating an inflammatory disease with compositions comprising polyunsaturated fatty acid monoglycerides, derivatives thereof and uses thereof
#2050Compositions comprising polyunsaturated fatty acid monoglycerides, derivatives thereof and uses thereof
#2051Emulsion and emulsion preconcentrate compositions comprising omega-3 fatty acids and uses thereof are disclosed
#2052USE OF AT LEAST ONE OMEGA-3 FATTY ACID AND OF AT LEAST ONE POLYPHENOL FOR THE ENDOGENOUS SYNTHESIS OF EICOSAPENTANOIC ACID AND DOCOSAHEXANOIC ACID
#2053Method and Composition for Improving Animal Oral Health
#2054Compositions and methods for treating macular edema
#2055Compositions comprising a fatty acid oil mixture comprising EPA and DHA in free acid form and a surfactant, and methods and uses thereof
#2056DIAGNOSIS AND TREATMENT OF THE PRODROMAL SCHIZOPHRENIC STATE
#2057HIGHLY PURIFIED ETHYL EPA AND OTHER EPA DERIVATIVES
#2058METHODS OF ATTENUATING THE LOSS OF FUNCTIONAL STATUS
#2059Fatty acid formulations and methods of use thereof
#2060Fatty acid niacin conjugates and their uses
#2061LIPID-LOWERING ANTIDIABETIC AGENT
#2062PHARMACEUTICAL COMPOSITIONS COMPRISING EPA AND A CARDIOVASCULAR AGENT AND METHODS OF USING THE SAME
#2063OMEGA 3 FATTY ACID FORMULATIONS
#2064Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
#2065METHOD FOR INCREASING INSULIN SENSITIVITY AND FOR TREATING AND PREVENTING TYPE 2 DIABETES
#2066COMPOSITIONS AND METHODS FOR LOWERING TRIGLYCERIDES
#2067METHODS OF TREATING HYPERTRIGLYCERIDEMIA
#2068METHODS OF TREATING HYPERTRIGLYCERIDEMIA
#2069COMPOSITIONS AND METHODS FOR IMPROVING CELLULAR SURVIVAL AND REDUCING APOPTOSIS AFTER ISCHEMIC EPISODE IN THE BRAIN
#2070METHODS FOR PREVENTING AND IMPROVING SKIN ELASTIC PROPERTY LOSS
#2071METHOD FOR TREATING AIRWAY HYPER-RESPONSIVENESS WITH LIPOXIN ANALOGS
#2072METHODS AND COMPOSITIONS FOR TREATING INSULIN RESISTANCE, DIABETES MELLITUS TYPE 2, METABOLIC SYNDROME AND RELATED DISORDERS
#2073Use of PUFAs for treating skin inflammation
#2074Methods for detecting inflammatory bowel disease in a feline
#2075Method of using punicic acid to enhance immune response and prevent metabolic disorders
#2076Oral Nutritional Supplement Delivery System
#2077HYDROXY FATTY ACID COMPOUNDS AND USES THEREOF FOR DISEASE TREATMENT AND DIAGNOSIS
#2078COPEPOD OIL COMPOSITION, FORMULATIONS COMPRISING THE OIL COMPOSITION, AND THE USE THEREOF TO REDUCE ACCUMULATION OF VISCERAL FAT, IMPROVE GLUCOSE TOLERANCE, AND PREVENT OR TREAT OBESITY RELATED DISEASES AND DISORDERS
#2079Nutrition with lipids and non-digestible saccharides
#2080Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders
#2081USE OF PUFAS TO TREAT NERVE DAMAGE
#2082COMPOSITIONS AND METHODS FOR ORGAN PRESERVATION
#2083COMBINATION OF A LEUCINE SOURCE AND AN OMEGA- 3 UNSATURATED FATTY ACID SOURCE FOR USE IN THE TREATMENT OF HYPERCALCAEMIA
#2084Infant nutritional compositions for preventing obesity
#2085Kits and methods for nutrition supplementation
#2086Pharmaceutical compositions comprising EPA and a cardiovascular agent and methods of using the same
#2087Method for Increasing the Production of a Specific ACYL-Chain Dihydroceramide(s) for Improving the Effectiveness of Cancer Treatments
#2088Lipoxin analogs and methods for the treatment of periodontal disease
#2089METHODS AND COMPOSITIONS FOR TREATING OPHTHALMIC CONDITIONS
#2090Methods of treating hypertriglyceridemia
#2091COMPOSITIONS AND METHODS FOR TREATING SKIN DISORDERS
#2092Methods of treating hypertriglyceridemia
#2093Methods of treating hypertriglyceridemia
#2094METHODS AND DOSAGE FORMS FOR THE TREATMENT OF HUMAN CANCERS
#2095Use of derivatives of polyunsaturated fatty acids as medicaments
#2096Lipid-containing compositions and methods of use thereof
#2097STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME
#2098COMPOSITIONS AND METHODS FOR THE PREVENTION OF CARDIOVASCULAR DISEASE
#2099Trans carotenoids, their synthesis, formulation and uses
#2100Bioavailability Enhancement Delivery System